Abstract
Regular keratinocyte differentiation is crucial for the formation of an intact epidermal barrier and is triggered by extracellular calcium. Disturbances of epidermal barrier formation and aberrant keratinocyte differentiation are involved in the pathophysiology of several skin diseases, such as psoriasis, atopic dermatitis, basal and squamous skin cancer, and genetic skin diseases such as Darier’s disease and Olmstedt syndrome. In this review, we summarize current knowledge about the underlying molecular mechanisms of calcium-induced differentiation in keratinocytes.We provide an overview of calcium’s genomic and non-genomic mechanisms to induce differentiation and discuss the calcium gradient in the epidermis, giving rise to cornified skin and lipid envelope formation.We focus on the calcium-sensing receptor, transient receptor potential channels, and STIM/Orai as the major constituents of calcium sensing and calcium entry in the keratinocytes. Finally, skin diseases linked to impaired differentiation will be discussed, paying special attention to disturbed TRP channel expression and TRP channel mutations.
Article PDF
Similar content being viewed by others
References
Marcelo CL, Kim YG, Kaine JL, Voorhees JJ. Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. J Cell Biol 1978; 79: 356–70.
Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6: 331–43.
Sun TT, Green H. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell 1976; 9: 511–21.
Bikle DD, Xie Z, Tu CL. Calcium regulation of keratinocyte differentiation. Expert Rev Endocrinol Metab 2012; 7: 461–72.
Tu CL, Crumrine DA, Man MQ, et al. Ablation of the calcium-sensing receptor in keratinocytes impairs epidermal differentiation and barrier function. J Invest Dermatol 2012; 132: 2350–9.
Rice RH, Green H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 1979; 18: 681–94.
Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063–72.
Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980; 19: 245–54.
Pillai S, Bikle DD, Hincenbergs M, Elias PM. Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J Cell Physiol 1988; 134: 229–37.
Hennings H, Holbrook KA. Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res 1983; 143: 127–42.
Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007; 127: 2525–32.
Ng DC, Su MJ, Kim R, Bikle DD. Regulation of involucrin gene expression by calcium in normal human keratinocytes. Front Biosci 1996; 1: a16–24.
Huff CA, Yuspa SH, Rosenthal D. Identification of control elements 3′ to the human keratin 1 gene that regulate cell type and differentiation-specific expression. J Biol Chem 1993; 268: 377–84.
Rothnagel JA, Greenhalgh DA, Gagne TA, Longley MA, Roop DR. Identification of a calcium-inducible, epidermal-specific regulatory element in the 3′-flanking region of the human keratin 1 gene. J Invest Dermatol 1993; 101: 506–13.
Seo EY, Namkung JH, Lee KM, et al. Analysis of calcium-inducible genes in keratinocytes using suppression subtractive hybridization and cDNA microarray. Genomics 2005; 86: 528–38.
Menon GK, Grayson S, Elias PM. Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 1985; 84: 508–12.
Menon GK, Elias PM. Ultrastructural localization of calcium in psoriatic and normal human epidermis. Arch Dermatol 1991; 127: 57–63.
Elias P, Ahn S, Brown B, Crumrine D, Feingold KR. Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J Invest Dermatol 2002; 119: 1269–74.
Mascia F, Denning M, Kopan R, Yuspa SH. The black box illuminated: signals and signaling. J Invest Dermatol 2012; 132: 811–9.
Behne MJ, Sanchez S, Barry NP, et al. Major translocation of calcium upon epidermal barrier insult: imaging and quantification via FLIM/Fourier vector analysis. Arch Dermatol Res 2011; 303: 103–15.
Celli A, Sanchez S, Behne M, Hazlett T, Gratton E, Mauro T. The epidermal Ca2+ gradient: measurement using the phasor representation of fluorescent lifetime imaging. Biophys J 2010; 98: 911–21.
Elias PM, Nau P, Hanley K, et al. Formation of the epidermal calcium gradient coincides with key milestones of barrier ontogenesis in the rodent. J Invest Dermatol 1998; 110: 399–404.
Menon GK, Elias PM, Feingold KR. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol 1994; 130: 139–47.
Mauro T, Bench G, Sidderas-Haddad E, Feingold K, Elias P, Cullander C. Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE. J Invest Dermatol 1998; 111: 1198–201.
Elias PM, Ahn SK, Denda M, et al. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J Invest Dermatol 2002; 119: 1128–36.
Bikle DD, Ratnam A, Mauro T, Harris J, Pillai S. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 1996; 97: 1085–93.
Fatherazi S, Belton CM, Cai S, et al. Calcium receptor message, expression and function decrease in differentiating keratinocytes. Pflügers Arch 2004; 448: 93–104.
Tu CL, Chang W, Bikle DD. The calcium-sensing receptor-dependent regulation of cell-cell adhesion and keratinocyte differentiation requires Rho and filamin A. J Invest Dermatol 2011; 131: 1119–28.
Popp T, Steinritz D, Breit A, et al. Wnt5a/β-catenin signaling drives calcium-induced differentiation of human primary keratinocytes. J Invest Dermatol. 2014; 134: 2183–91.
Tu CL, Chang W, Xie Z, Bikle DD. Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes. J Biol Chem 2008; 283: 3519–28.
Tu CL, Chang W, Bikle DD. The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes. J Biol Chem 2001; 276: 41079–85.
Komuves L, Oda Y, Tu CL, et al. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 2002; 192: 45–54.
Tu CL, Chang W, Bikle DD. The role of the calcium sensing receptor in regulating intracellular calcium handling in human epidermal keratinocytes. J Invest Dermatol 2007; 127: 1074–83.
Fatherazi S, Presland RB, Belton CM, et al. Evidence that TRPC4 supports the calcium selective I(CRAC)-like current in human gingival keratinocytes. Pflügers Arch 2007; 453: 879–89.
Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999; 397: 259–63.
Okada T, Inoue R, Yamazaki K, et al. Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7. Ca2+-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor. J Biol Chem 1999; 274: 27359–70.
Müller M, Essin K, Hill K, et al. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem 2008; 283: 33942–54.
Tu CL, Bikle DD. Role of the calcium-sensing receptor in calcium regulation of epidermal differentiation and function. Best Pract Res Clin Endocrinol Metab 2013; 27: 415–27.
Cai S, Fatherazi S, Presland RB, Belton CM, Izutsu KT. TRPC channel expression during calcium-induced differentiation of human gingival keratinocytes. J Dermatol Sci 2005; 40: 21–8.
Peier AM, Reeve AJ, Andersson DA, et al. A heat-sensitive TRP channel expressed in keratinocytes. Science 2002; 296: 2046–9.
Kida N, Sokabe T, Kashio M, et al. Importance of transient receptor potential vanilloid 4 (TRPV4) in epidermal barrier function in human skin keratinocytes. Pflügers Arch 2012; 463: 715–25.
Lee YM, Kang SM, Chung JH. The role of TRPV1 channel in aged human skin. J Dermatol Sci 2012; 65: 81–5.
Denda M, Tsutsumi M, Denda S. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis. Exp Dermatol 2010; 19: 791–5.
Atoyan R, Shander D, Botchkareva NV. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol 2009; 129: 2312–5.
Clapham DE, Runnels LW, Strübing C. The TRP ion channel family. Nat Rev Neurosci 2001; 2: 387–96.
Pani B, Cornatzer E, Cornatzer W, et al. Up-regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier’s disease. Mol Biol Cell 2006; 17: 4446–58.
Leuner K, Kraus M, Woelfle U, et al. Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One 2011; 6: e14716.
Cai S, Fatherazi S, Presland RB, et al. Evidence that TRPC1 contributes to calcium-induced differentiation of human keratinocytes. Pflügers Arch 2006; 452: 43–52.
Beck B, Lehen’kyi V, Roudbaraki M, et al. TRPC channels determine human keratinocyte differentiation: new insight into basal cell carcinoma. Cell Calcium 2008; 43: 492–505.
Woelfle U, Laszczyk MN, Kraus M, et al. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6. J Invest Dermatol 2010; 130: 113–23.
Nilius B, Voets T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflügers Arch 2005; 451: 1–10.
Radtke C, Sinis N, Sauter M, et al. TRPV channel expression in human skin and possible role in thermally induced cell death. J Burn Care Res 2011; 32: 150–9.
Chung MK, Lee H, Mizuno A, Suzuki M, Caterina MJ. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytes. J Biol Chem 2004; 279: 21569–75.
Mandadi S, Sokabe T, Shibasaki K, et al. TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflügers Arch 2009; 458: 1093–102.
Denda M, Fuziwara S, Inoue K, et al. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 2001; 285: 1250–2.
Bodó E, Bíró T, Telek A, et al. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005; 166: 985–98.
Tóth BI, Dobrosi N, Dajnoki A, et al. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 2011; 131: 1095–104.
Lee YM, Kim YK, Kim KH, Park SJ, Kim SJ, Chung JH. A novel role for the TRPV1 channel in UV-induced matrix metalloproteinase (MMP)-1 expression in HaCaT cells. J Cell Physiol 2009; 219: 766–75.
Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003; 304: 217–22.
Huang J, Ding L, Shi D, et al. Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E2 production in HaCaT cells. J Pharm Pharmacol 2012; 64: 252–8.
Lee YM, Kang SM, Lee SR, et al. Inhibitory effects of TRPV1 blocker on UV-induced responses in the hairless mice. Arch Dermatol Res 2011; 303: 727–36.
Steinhoff M, Bíró T. A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch. J Invest Dermatol 2009; 129: 531–5.
Bang S, Yoo S, Yang TJ, Cho H, Hwang SW. Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem 2010; 285: 19362–71.
Nilius B, Bíró T. TRPV3: a “more than skinny” channel. Exp Dermatol 2013; 22: 447–52.
Nilius B, Bíró T, Owsianik G. TRPV3: time to decipher a poorly understood family member! J Physiol 2014; 592: 295–304.
Cheng X, Jin J, Hu L, et al. TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell 2010; 141: 331–43.
Miyamoto T, Petrus MJ, Dubin AE, Patapoutian A. TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin. Nat Commun 2011; 2: 369.
Sokabe T, Fukumi-Tominaga T, Yonemura S, Mizuno A, Tominaga M. The TRPV4 channel contributes to intercellular junction formation in keratinocytes. J Biol Chem 2010; 285: 18749–58.
Lehen’kyi V, Beck B, Polakowska R, et al. TRPV6 is a Ca2+ entry channel essential for Ca2+-induced differentiation of human keratinocytes. J Biol Chem 2007; 282: 22582–91.
Bikle DD, Gee E, Pillai S. Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol 1993; 101: 713–8.
Bíró T, Kovács L. An “ice-cold” TR(i)P to skin biology: the role of TRPA1 in human epidermal keratinocytes. J Invest Dermatol 2009; 129: 2096–9.
Jain A, Brönneke S, Kolbe L, Stäb F, Wenck H, Neufang G. TRP-channel-specific cutaneous eicosanoid release patterns. Pain 2011; 152: 2765–72.
Silva CR, Oliveira SM, Rossato MF, et al. The involvement of TRPA1 channel activation in the inflammatory response evoked by topical application of cinnamaldehyde to mice. Life Sci 2011; 88: 1077–87.
Shiba T, Maruyama T, Kurohane K, Iwasaki Y, Watanabe T, Imai Y. TRPA1 and TRPV1 activation is a novel adjuvant effect mechanism in contact hypersensitivity. J Neuroimmunol 2009; 207: 66–74.
Tsutsumi M, Denda S, Ikeyama K, Goto M, Denda M. Exposure to low temperature induces elevation of intracellular calcium in cultured human keratinocytes. J Invest Dermatol 2010; 130: 1945–8.
Kraft R, Harteneck C. The mammalian melastatin-related transient receptor potential cation channels: an overview. Pflügers Arch 2005; 451: 204–11.
Kurohane K, Sahara Y, Kimura A, et al. Lack of transient receptor potential melastatin 8 activation by phthalate esters that enhance contact hypersensitivity in mice. Toxicol Lett 2013; 217: 192–6.
Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315–21.
Liou J, Kim ML, Heo Do W, et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 2005; 15: 1235–41.
Roos J, DiGregorio PJ, Yeromin AV, et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol 2005; 169: 435–45.
Várnai P, Hunyady L, Balla T. STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 2009; 30: 118–28.
Vig M, Peinelt C, Beck A, et al. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 2006; 312: 1220–3.
Ross K, Whitaker M, Reynolds NJ. Agonist-induced calcium entry correlates with STIM1 translocation. J Cell Physiol 2007; 211: 569–76.
Numaga-Tomita T, Putney JW. Role of STIM1 and Orai1-mediated calcium entry in Ca2+-induced epidermal keratinocyte differentiation. J Cell Sci 2013; 126: 605–12.
Jans R, Mottram L, Johnson DL, et al. Lysophosphatidic acid promotes cell migration through STIM1- and Orai1-mediated Ca2+(i) mobilization and NFAT2 activation. J Invest Dermatol 2013; 133: 793–802.
Gwack Y, Srikanth S, Oh-Hora M, et al. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 2008; 28: 5209–22.
Saul S, Stanisz H, Backes CS, Schwarz EC, Hoth M. How ORAI and TRP channels interfere with each other: interaction models and examples from the immune system and the skin. Eur J Pharmacol 2013. pii: S0014-2999(13)00882-0.
Moran MM, McAlexander MA, Bíró T, Szallasi A. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 2011; 10: 601–20.
Ross SE. Pain and itch: insights into the neural circuits of aversive somatosensation in health and disease. Curr Opin Neurobiol 2011; 21: 880–7.
Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899–912.
Quatresooz P, Hermanns-Lê T, Piérard GE, Humbert P, Delvenne P, Piérard-Franchimont C. Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer. J Biomed Biotechnol 2012; 2012: 147413.
Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 2012; 9: 302–9.
Chong HT, Kopecki Z, Cowin AJ. Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis. Biomed Res Int 2013; 2013: 168321.
Karvonen SL, Korkiamäki T, Ylä-Outinen H, et al. Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol 2000; 114: 693–700.
Cohen AD, Kagen M, Friger M, Halevy S. Calcium channel blockers intake and psoriasis: a case-control study. Acta Derm Venereol 2001; 81: 347–9.
Ioulios P, Charalampos M, Efrossini T. The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms. Dermatol Online J 2003; 9: 6.
Feske S, Skolnik EY, Prakriya M. Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol 2012; 12: 532–47.
Eichenfield LF, Ellis CN, Mancini AJ, Paller AS, Simpson EL. Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg 2012; 31: S3–5.
Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clin Dermatol 2012; 30: 329–34.
Bos JD, Brenninkmeijer EEA, Schram ME, Middelkamp-Hup MA, Spuls PI, Smitt JHS. Atopic eczema or atopiform dermatitis. Exp Dermatol 2010; 19: 325–31.
Howell MD, Fairchild HR, Kim BE, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008; 128: 2248–58.
Kim BE, Leung DYM, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126: 332–7.
Boguniewicz M, Leung DYM. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233–46.
Sun XD, You Y, Zhang L, et al. The possible role of TRPC6 in atopic dermatitis. Med Hypotheses 2012; 78: 42–4.
Beck B, Zholos A, Sydorenko V, et al. TRPC7 is a receptor-operated DAG-activated channel in human keratinocytes. J Invest Dermatol 2006; 126: 1982–93.
Leuner K, Kazanski V, Müller M, et al. Hyperforin-a key constituent of St. John’s wort specifically activates TRPC6 channels. FASEB J 2007; 21: 4101–11.
Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC. Topical application of St John’s wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 2000; 142: 979–84.
Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. John’s wort cream-a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 2003; 4(10 Suppl): 31–7.
Shim WS, Tak MH, Lee MH, et al. TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 2007; 27: 2331–7.
Yun JW, Seo JA, Jang WH, et al. Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models. J Invest Dermatol 2011; 131: 1576–9.
Yun JW, Seo JA, Jeong YS, et al. TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J Dermatol Sci 2011; 62: 8–15.
Yoshioka T, Imura K, Asakawa M, et al. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J Invest Dermatol 2009; 129: 714–22.
Asakawa M, Yoshioka T, Matsutani T, et al. Association of a mutation in TRPV3 with defective hair growth in rodents. J Invest Dermatol 2006; 126: 2664–72.
Yamamoto-Kasai E, Imura K, Yasui K, et al. TRPV3 as a therapeutic target for itch. J Invest Dermatol 2012; 132: 2109–12.
Xu H, Delling M, Jun JC, Clapham DE. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci 2006; 9: 628–35.
Tóth BI, Oláh A, Szöllősi AG, Bíró T. TRP channels in the skin. Br J Pharmacol 2014; 171: 2568-81.
Savignac M, Edir A, Simon M, Hovnanian A. Darier disease: a disease model of impaired calcium homeostasis in the skin. Biochim Biophys Acta 2011; 1813: 1111–7.
Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet 1999; 21: 271–7.
Celli A, Mackenzie DS, Zhai Y, et al. SERCA2-controlled Ca2+-dependent keratinocyte adhesion and differentiation is mediated via the sphingolipid pathway: a therapeutic target for Darier’s disease. J Invest Dermatol 2012; 132: 1188–95.
Pani B, Singh BB. Darier’s disease: a calcium-signaling perspective. Cell Mol Life Sci 2008; 65: 205–11.
Shull GE, Miller ML, Prasad V. Secretory pathway stress responses as possible mechanisms of disease involving Golgi Ca2+ pump dysfunction. Biofactors 2011; 37: 150–8.
Więeckiewicz W, Bieniek A, Więckiewicz M, Sroczyk L. Interdisciplinary treatment of BCC located on the nose-review of literature. Adv Clin Exp Med 2013; 22: 289–93.
Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 2012; 122: 464–72.
Fusi C, Materazzi S, Minocci D, et al. Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer. J Invest Dermatol 2014. doi: 10.1038/jid.2014.145.
Pillai S, Bikle DD, Mancianti ML, Hincenbergs M. Uncoupling of the calcium-sensing mechanism and differentiation in squamous carcinoma cell lines. Exp Cell Res 1991; 192: 567–73.
Moore C, Cevikbas F, Pasolli HA, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci USA 2013; 110: E3225–34.
Lin Z, Chen Q, Lee M, et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet 2012; 90: 558–64.
Lai-Cheong JE, Sethuraman G, Ramam M, Stone K, Simpson MA, McGrath JA. Recurrent heterozygous missense mutation, p.Gly573Ser, in the TRPV3 gene in an Indian boy with sporadic Olmsted syndrome. Br J Dermatol 2012; 167: 440–2.
Attia AM, Bakry OA. Olmsted syndrome. J Dermatol Case Rep 2013; 7: 42–5.
Kariminejad A, Barzegar M, Abdollahimajd F, Pramanik R, McGrath JA. Olmsted syndrome in an Iranian boy with a new de novo mutation in TRPV3. Clin Exp Dermatol 2014; 39: 492–5.
Eytan O, Fuchs-Telem D, Mevorach B, et al. Olmsted syndrome caused by a homozygous recessive mutation in TRPV3. J Invest Dermatol 2014; 134: 1752–4.
Lin Z, Chen Q, Lee M, et al. Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet 2012; 90: 558–64.
Duchatelet S, Guibbal L, de Veer S, et al. Olmsted syndrome with erythromelalgia caused by recessive TRPV3 mutations. Br J Dermatol. 2014. doi: 10.1111/bjd.12951.
Hammerland LG, Garrett JE, Hung BC, Levinthal C, Nemeth EF. Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 1998; 53: 1083–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Elsholz, F., Harteneck, C., Muller, W. et al. Calcium — a central regulator of keratinocyte differentiation in health and disease. Eur J Dermatol 24, 650–661 (2014). https://doi.org/10.1684/ejd.2014.2452
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2014.2452